Gain-of-function of KCa2.3 mutations is associated with the Zimmermann–Laband syndrome (ZLS) [78,79] and idiopathic non-cirrhotic portal hypertension (INCPH) [80]. This evidence concerns the gene KCNN3 and Zimmermann-Laband syndrome.